Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
6.24
0.00
(0.00%)
At close: March 12 at 8:55:34 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DAGNON TERRY Chief Operating Officer | Sale | Apr 20, 2023 | 653,058 |
| EVANSON JEFF Officer | Purchase | Mar 7, 2024 | 808,459 |
| HADDADIN YEZAN MUNTHER Director | Purchase | Mar 28, 2024 | 5,048 |
| KENYON LAWRENCE A. Chief Financial Officer | Purchase | Sep 26, 2024 | 5,946 |
| SUKHTIAN GHIATH M Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 17, 2025 | -- |
| SYNTONE VENTURES, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 15, 2024 | 1,705,440 |
Related Tickers
LYRA Lyra Therapeutics, Inc.
0.1923
+2.18%
AGE
EYPT EyePoint Pharmaceuticals, Inc.
7.13
+4.55%
DARE Daré Bioscience, Inc.
2.9500
-2.64%
XFOR X4 Pharmaceuticals, Inc.
0.3518
-6.21%
VERU Veru Inc.
0.5133
-2.82%
MIRM Mirum Pharmaceuticals, Inc.
43.46
+0.09%
LQDA Liquidia Corporation
14.82
-0.27%
ATNM Actinium Pharmaceuticals, Inc.
1.1400
0.00%
SPRB Spruce Biosciences, Inc.
0.3532
-1.73%